Alpa Laboratories
Alpa Laboratories Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Alpa Laboratories
Start SIPAlpa Laboratories Investment Rating
-
Master Rating:
-
Alpa Laboratories has an operating revenue of Rs. 88.44 Cr. on a trailing 12-month basis. An annual revenue growth of 21% is outstanding, Pre-tax margin of 17% is great, ROE of 11% is good. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 64 which is a FAIR score but needs to improve its earnings, a RS Rating of 33 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 84 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 27 | 14 | 22 | 26 |
| Operating Expenses Qtr Cr | 25 | 19 | 21 | 27 |
| Operating Profit Qtr Cr | 3 | -6 | 1 | -1 |
| Depreciation Qtr Cr | 0 | 0 | 0 | 0 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 0 | 0 | 0 | 5 |
| Net Profit Qtr Cr | 5 | 0 | 3 | -4 |
Alpa Laboratories Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- 55.27
- 50 Day
- 58.26
- 100 Day
- 59.81
- 200 Day
- 61.18
- 20 Day
- 55.64
- 50 Day
- 60.76
- 100 Day
- 59.96
- 200 Day
- 60.55
Alpa Laboratories Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 53.6 |
| Second Resistance | 56.55 |
| Third Resistance | 58.2 |
| RSI | 35.35 |
| MFI | 16.73 |
| MACD Single Line | -2.06 |
| MACD | -2.25 |
| Support | |
|---|---|
| First Resistance | 49 |
| Second Resistance | 47.35 |
| Third Resistance | 44.4 |
Alpa Laboratories Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 45,700 | 2,823,346 | 61.78 |
| Week | 35,859 | 2,140,089 | 59.68 |
| 1 Month | 41,003 | 2,237,923 | 54.58 |
| 6 Month | 191,955 | 6,537,984 | 34.06 |
Alpa Laboratories Result Highlights
Alpa Laboratories Synopsis
NSE-Medical-Generic Drugs
Alpa Laboratories Lt is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 112.27 Cr. and Equity Capital is Rs. 21.04 Cr. for the Year ended 31/03/2022. Alpa Laboratories Ltd. is a Public Limited Listed company incorporated on 18/03/1988 and has its registered office in the State of Madhya Pradesh, India. Company’s Corporate Identification Number(CIN) is L85195MP1988PLC004446 and registration number is 004446.| Market Cap | 109 |
| Sales | 89 |
| Shares in Float | 0.90 |
| No of funds | 1 |
| Yield |
| Book Value | 0.83 |
| U/D Vol ratio | 2.8 |
| LTDebt / Equity | 2 |
| Alpha | -0.03 |
| Beta | 0.98 |
Alpa Laboratories
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 57.29% | 57.29% | 57.29% | |
| Foreign Portfolio Investors | 0.14% | 0.21% | ||
| Individual Investors | 37.88% | 37.72% | 37.93% | |
| Others | 4.83% | 4.85% | 4.57% |
Alpa Laboratories Management
| Name | Designation |
|---|---|
| Mr. Mahendra Singh Chawla | Chairman |
| Mr. Paresh Chawla | Managing Director |
| Mr. Devendra Baheti | Independent Director |
| Mr. Sharad Chand Lunawat | Independent Director |
| Mr. Krishna Das Malani | Independent Director |
| Mrs. Jyoti Jain | Independent Director |
| Mr. Pravin Shah | Director |
Alpa Laboratories Forecast
Price Estimates
Alpa Laboratories FAQs
What is Share Price of Alpa Laboratories ?
Alpa Laboratories share price is ₹51 As on 30 March, 2023 | 13:45
What is the Market Cap of Alpa Laboratories ?
The Market Cap of Alpa Laboratories is ₹109 Cr As on 30 March, 2023 | 13:45
What is the P/E ratio of Alpa Laboratories ?
The P/E ratio of Alpa Laboratories is 24 As on 30 March, 2023 | 13:45
What is the PB ratio of Alpa Laboratories ?
The PB ratio of Alpa Laboratories is 0.9 As on 30 March, 2023 | 13:45